Skip to main content
Log in

Functional Analysis of SNPs Variants of BCRP/ABCG2

Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The aim of the current study was to identify the effect of single nucleotide polymorphisms (SNPs) in breast cancer resistance protein (BCRP/ABCG2) on its localization, expression level, and transport activity.

Methods. The cellular localization was identified using the wild type and seven different SNP variants of BCRP (V12M, Q141K, A149P, R163K, Q166E, P269S, and S441N BCRP) after transfection of their cDNAs in plasmid vector to LLC-PK1 cells. Their expression levels and transport activities were determined using the membrane vesicles from HEK293 cells infected with the recombinant adenoviruses containing these kinds of BCRP cDNAs.

Results. Wild type and six different SNP variants of BCRP other than S441N BCRP were expressed on the apical membrane, whereas S441N BCRP showed intracellular localization. The expression levels of Q141K and S441N BCRP proteins were significantly lower compared with the wild type and the other five variants. Furthermore, the transport activity of E1S, DHEAS, MTX, and PAH normalized by the expression level of BCRP protein was almost the same for the wild type, V12M, Q141K, A149P, R163K, Q166E, and P269S BCRP.

Conclusions. These results suggest that Q141K SNPs may associate with a lower expression level, and S441N SNPs may affect both the expression level and cellular localization. It is possible that subjects with these polymorphisms may have lower expression level of BCRP protein and, consequently, a reduced ability to export these substrates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. L. A. Doyle, W. Yang, L. V. Abruzzo, T. Krogmann, Y. Gao, A. K. Rishi, and D. D. Ross. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA 95:15665–15670 (1998).

    Google Scholar 

  2. K. Miyake, T. Litman, R. Robey, and S. E. Bates. Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR. Cancer Lett. 146:117–126 (1999).

    Google Scholar 

  3. R. Allikmets, L. M. Schriml, A. Hutchinson, V. Romano-Spica, and M. Dean. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 58:5337–5339 (1998).

    Google Scholar 

  4. J. D. Allen, R. F. Brinkhuis, J. Wijnholds, and A. H. Schinkel. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpres-sion in cell lines selected for resistance to topotecan, mitoxan-trone, or doxorubicin. Cancer Res. 59:4237–4241 (1999).

    Google Scholar 

  5. K. J. Bailey-Dell, B. Hassel, L. A. Doyle, and D. D. Ross. Pro-moter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene. Biochim. Biophys. Acta 1520:234–241 (2001).

    Google Scholar 

  6. K. Kage, S. Tsukahara, T. Sugiyama, S. Asada, E. Ishikawa, T. Tsuruo, and Y. Sugimoto. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhi-bition of S-S dependent homodimerization. Int. J. Cancer 97:626–630 (2002).

    Google Scholar 

  7. T. Litman, T. E. Druley, W. D. Stein, and S. E. Bates. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 58: 931–959 (2001).

    Google Scholar 

  8. M. Maliepaard, G. L. Scheffer, I. F. Faneyte, M. A. van Gastelen, A. C. Pijnenborg, A. H. Schinkel, M. J. van De Vijver, R. J. Scheper, and J. H. Schellens. Subcellular localization and distri-bution of the breast cancer resistance protein transporter in nor-mal human tissues. Cancer Res. 61:3458–3464 (2001).

    Google Scholar 

  9. J. W. Jonker, J. W. Smit, R. F. Brinkhuis, M. Maliepaard, J. H. Beijnen, J. H. Schellens, and A. H. Schinkel. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 92:1651–1656 (2000).

    Google Scholar 

  10. J. W. Jonker, M. Buitelaar, E. Wagenaar, M. A. van der Valk, G. L. Scheffer, R. J. Scheper, T. Plosch, F. Kuipers, R. P. Oude Elferink, H. Rosing, J. H. Beijnen, and A. H. Schinkel. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA 99:15649–15654 (2002).

    Google Scholar 

  11. M. Suzuki, H. Suzuki, Y. Sugimoto, and Y. Sugiyama. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J. Biol. Chem. 278:22644–22649 (2003).

    Google Scholar 

  12. Y. Honjo, C. A. Hrycyna, Q. W. Yan, W. Y. Medina-Perez, R. W. Robey, A. van de Laar, T. Litman, M. Dean, and S. E. Bates. Acquired mutations in the MXR/BCRP/ABCP gene alter sub-strate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res. 61:6635–6639 (2001).

    Google Scholar 

  13. H. Mitomo, R. Kato, A. Ito, S. Kasamatsu, Y. Ikegami, I. Kii, A. Kudo, E. Kobatake, Y. Sumino, and T. Ishikawa. A functional study on polymorphism of the ATP-binding cassette transporter ABCG2: critical role of arginine-482 in methotrexate transport. Biochem. J. 373:767–774 (2003).

    Google Scholar 

  14. M. Itoda, Y. Saito, K. Shirao, H. Minami, A. Ohtsu, T. Yoshida, N. Saijo, H. Suzuki, Y. Sugiyama, S. Ozawa, and J.-I. Sawada. Eight novel single nucleotide polymorphisms in ABCG2/BCRPin Japanese cancer patients administered irinotecan. Drug Metab. Pharmacokinet. 18:212–217 (2003).

    Google Scholar 

  15. H. Mizuguchi and M. A. Kay. Efficient construction of a recom binant adenovirus vector by an improved in vitro ligation method. Hum. Gene Ther. 9:2577–2583 (1998).

    Google Scholar 

  16. H. Mizuguchi and M. A. Kay. A simple method for constructing E1-and E1/E4-deleted recombinant adenoviral vectors. Hum. Gene Ther. 10:2013–2017 (1999).

    Google Scholar 

  17. M. Muller, C. Meijer, G. J. Zaman, P. Borst, R. J. Scheper, N. H. Mulder, E. G. de Vries, and P. L. Jansen. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91:13033–13037 (1994).

    Google Scholar 

  18. T. Hirohashi, H. Suzuki, X. Y. Chu, I. Tamai, A. Tsuji, and Y. Sugiyama. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292:265–270 (2000).

    Google Scholar 

  19. Y. Imai, M. Nakane, K. Kage, S. Tsukahara, E. Ishikawa, T. Tsuruo, Y. Miki, and Y. Sugimoto. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol. Cancer Ther. 1:611–616 (2002).

    Google Scholar 

  20. C. P. Zamber, J. K. Lamba, K. Yasuda, J. Farnum, K. Thummel, J. D. Schuetz, and E. G. Schuetz. Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine. Pharmacogenetics 13:19–28 (2003).

    Google Scholar 

  21. G. Backstrom, J. Taipalensuu, H. Melhus, H. Brandstrom, A. C. Svensson, P. Artursson, and A. Kindmark. Genetic variation in the ATP-binding Cassette Transporter gene ABCG2 (BCRP) in a Swedish population. Eur. J. Pharm. Sci. 18:359-364 (2003).

    Google Scholar 

  22. K. Hashimoto, T. Uchiumi, T. Konno, T. Ebihara, T. Nakamura, M. Wada, S. Sakisaka, F. Maniwa, T. Amachi, K. Ueda, and M. Kuwano. Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome. Hepatology 36:1236–1245 (2002).

    Google Scholar 

  23. S. Mizuarai, N. Aozasa, and H. Kotani. Single nucleotide polymorphisms result in impaired membrane localization and re-duced ATPase activity in multidrug transporter ABCG2. Int. J. Cancer 109:238–246(2004).

    Google Scholar 

  24. E. L. Volk and E. Schneider. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methorexate polyglutamate trans-porter. Cancer Res. 63:5538–5543 (2003).

    Google Scholar 

  25. Z. S. Chen, R. W. Robey, M. G. Belinsky, I. Shchaveleva, X. Q. Ren, Y. Sugimoto, D. D. Ross, S. E. Bates, and G. D. Kruh. Transport of methotrexate, methotrexate polyglutamates, and 17_ estraciol 17_-D-glucuronide by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res. 64: 4048–4054 (2003).

    Google Scholar 

  26. S. Zhou, J. J. Morris, Y. Barnes, L. Lan, J. D. Schuetz, and B. P. Sorrentino. Bcrp1 gene expression is required for normal num-bers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA 99:12339–12344 (2002).

    Google Scholar 

  27. J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J. Pharmacol. Exp. Ther. 299:164–170 (2001).

    Google Scholar 

  28. K. Nakatomi, M. Yoshikawa, M. Oka, Y. Ikegami, S. Hayasaka, K. Sano, K. Shiozawa, S. Kawabata, H. Soda, T. Ishikawa, S. Tanabe, and S. Kohno. Transport of 7-ethyl-10-hydroxy-camptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun. 288:827–832 (2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kondo, C., Suzuki, H., Itoda, M. et al. Functional Analysis of SNPs Variants of BCRP/ABCG2. Pharm Res 21, 1895–1903 (2004). https://doi.org/10.1023/B:PHAM.0000045245.21637.d4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAM.0000045245.21637.d4

Navigation